EpistrySign in
LimitedMetadata only — full assessment not yet run

Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects

Roohi Mohi-ud-din, Apporva Chawla, Pooja Sharma, Prince Ahad Mir, Faheem Hyder Potoo, Željko Reiner, I Reiner, Dilek Arslan Ateşşahin, Javad Sharifi‐Rad, Reyaz Hassan Mir, Daniela Călina · European journal of medical research · 2023

DOI 10.1186/s40001-023-01275-4

Why this label

  • Metadata only — full assessment not yet run.

The Paper Scorecard

  • Standingclear
    • No retraction on record (OpenAlex metadata as of 2026-08-23).
  • Designjournal article
    • Journal article (European journal of medical research). Study design detail comes from the methodology read, not metadata.
  • Executionnot assessed
    • Metadata only — full assessment not yet run.
  • Corroborationcited
    • Cited by 78 works (OpenAlex citation count).
  • Provenanceidentified
    • Published in European journal of medical research.
    • Publisher: BioMed Central.
    • ISSN 0949-2321.
    • The journal is listed in DOAJ.
    • Open-access status: gold.
Assessed by Epistry · metadata as of August 23, 2026
Repurposing approved non-oncology drugs for cancer therapy: a compreh… — Epistry